Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates
Cells · 2025
DOI: 10.3390/cells14120907 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Xiaodi Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Hauptthemen laut MEDLINE: alpha-Synuclein, Positron-Emission Tomography, Protein Aggregates, Radiopharmaceuticals. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Neurodegenerative diseases (NDDs) that are characterized by the accumulation of alpha-synuclein (α-syn) aggregates in both neurons and the non-neuronal cells of the brain are called synucleinopathies. The most common synucleinopathies includes Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB). Significant progress has been made in the development of positron emission tomography (PET) radiotracers for synucleinopathies, yielding several α-syn tracers that have entered clinical studies. However, selective α-syn imaging still faces inherent challenges. This review provides a comprehensive overview of the progress in α-syn PET radiotracers from three angles: Alzheimer’s disease (AD)-derived scaffolds, representative compound scaffolds and analogs, and the identification of α-syn tracers through high-throughput screening (HTS). We discuss the characteristics, advantages, and limitations of the tracers for preclinical and clinical application. Finally, future directions in the development of radioligands for proteinopathies are discussed. There is no clinical available PET radiotracer for imaging α-syn aggregates, but these advances have laid a key foundation for non-invasive α-syn imaging and early diagnosis of synucleinopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Neurobiology, Fourth Military Medical University, Xi'an 710032, China.
- Faculty of Life and Health Sciences, Shenzhen University of Advanced Technology (SUAT), Shenzhen 518055, China.
- TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan 430000, China.
ORCID-Profile: Xiaodi Guo, Zhentao Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, X., Xiang, J., Ye, K., & Zhang, Z. (2025). Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates. Cells. https://doi.org/10.3390/cells14120907
Vancouver
Guo X, Xiang J, Ye K, Zhang Z. Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates. Cells. 2025. doi:10.3390/cells14120907
BibTeX
@article{Guo2025,
author = {Guo, Xiaodi and Xiang, Jie and Ye, Keqiang and Zhang, Zhentao},
title = {Development of Positron Emission Tomography Radiotracers for Imaging α-Synuclein Aggregates},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14120907}
}
EUVIMED